Author

admin

Browsing

The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition.

While global investment in renewable energy is strong, notable pullbacks in US spending and regulatory challenges under the Trump administration have clouded the near-term cleantech outlook. Electric vehicle (EV) sales showed mixed trends, with a rush observed ahead of the phase-out of American federal tax incentives at the end of September.

The quarter was also marked by several major mergers, funding rounds and technological developments.

Regulatory currents and investment flows shape cleantech market

The third quarter began with important cleantech policy signals and shifts in industry strategy.

Although global capital flows into renewables reached a record US$386 billion in H1 2025, according to data analyzed by BloombergNEF, a steep 36 percent year-on-year drop in US renewable project spending reflects investor uncertainty in response to changing policy conditions and the expiration of tax incentives.

Regulatory headwinds took center stage as the US Environmental Protection Agency under Lee Zeldin sought to overturn the agency’s scientific findings on greenhouse gases, stirring debate on climate regulatory directions.

Meanwhile, the Trump administration’s Department of the Interior moved to halt the planned US$6 billion Maryland offshore wind project, and paused work on Orsted’s (CPH: ORSTED,OTC Pink:DNNGY) Rhode Island offshore wind farm, triggering market pushback and state-level efforts to resume construction.

A judge later allowed the continuation of construction on the Rhode Island wind farm amid legal challenges.

While offshore wind faced setbacks from regulatory halts and legal challenges, the US solar sector demonstrated resilience, experiencing a notable 25 percent increase in corporate M&A activity in H1.

That increase was highlighted by Brookfield Renewable Partners’ (NYSE:BEP) US$2.8 billion acquisition of Duke Energy’s (NYSE:DUK) solar assets, as well as FlexGen’s purchase of Powin.

During Climate Week NYC, power giant Constellation Energy (NASDAQ:CEG) CEO Joseph Dominguez noted the potential for consolidation in the renewables sector. Despite federal tax credit phase-outs, wind and solar are supported by over 30 state-level programs, creating evolving investment opportunities for well-capitalized companies.

Adding to this insight, former US Vice President Al Gore emphasized the need to reconsider nuclear power as artificial intelligence (AI) electricity demand grows. While skeptical about the high costs of small modular reactors, Gore sees fusion power as promising, but probably farther off than some optimists predict.

He acknowledged that green hydrogen sentiment is overly optimistic, noting that its “bubble has burst” due to slow cost declines, although it retains promise for heavy industry uses like low-emissions steel production.

Aside from that, Gore referred to direct air capture as “overhyped” and not a “safe bet,” while calling deep geothermal “properly hyped,” but with uncertain commercial timelines.

At the same time, US Secretary of Energy Chris Wright indicated that an overhaul of permitting processes would expedite energy infrastructure projects facing intense opposition; however, the government shutdown, now heading into its third week, has created significant uncertainty and will likely lead to further delays.

Despite perceived setbacks, Q3 brought private sector investment in scalable clean infrastructure. Investors increasingly backed cleantech initiatives focused on transformative growth and digital infrastructure aligned with the evolving energy transition. Notable financing rounds went toward low-carbon data centers and battery storage. Investments like climate fintech firm Eventual’s US$7.5 million in seed funding also hint at growing investor interest.

These cleantech sector developments highlight a complex landscape where regulatory challenges in the US coexist with ongoing innovation and investment momentum, setting the stage for a critical period of adjustment and opportunity in the renewable energy sector, both above and below the American border.

In an interview with the Globe and Mail, Jigar Shah, former director of the Loans Program Office in the US Department of Energy, said Canadian cleantech firms have an opportunity to fill the void left in the industry by the US, but that decisive action is required to prevent companies from seeking out other jurisdictions.

Twists and turns in the EV race

The third quarter marked a pivotal period for the EV market.

Cox Automotive forecast in September that EV sales would hit a record of 409,000 units in Q3, in line with previous estimates that predicted a surge as buyers rushed in before the end of the US federal EV tax credit.

Automakers Ford Motor (NASDAQ:F), General Motors (NYSE:GM) and Hyundai Motor (KRX:005380,OTC Pink:HYMTF), all of which have extended EV discounts to after the expiration of the tax credit, reported record EV sales in Q3, with Ford’s EV sales rising over 30 percent, and GM’s EV sales more than doubling thanks to a diverse product lineup under the Chevrolet and Cadillac brands. Hyundai showed a 13 percent year-on-year increase, driven by EV sales.

In September, Ford announced a multibillion-dollar investment in American EV manufacturing facilities to pioneer a novel, efficient assembly process, aiming for a 2027 launch of a competitively priced midsize electric pickup.

Tesla’s (NASDAQ:TSLA) third quarter deliveries also hit a record, with estimates showing about 149,500 units, slightly higher compared to the 143,535 units reported in the second quarter. However, Cox Automotive’s numbers show that the company’s US market share has been steadily decreasing, slipping to 38 percent in August.

CEO Elon Musk said that the company will devote more of its resources to developing AI-driven autonomy going forward. Its robotaxi program officially launched this quarter, with initial testing beginning on July 1. The company reportedly experienced three crashes on its first day, underscoring ongoing technical hurdles. The National Highway Traffic Safety Administration has since launched another investigation into Tesla vehicles’ full self-driving technology, its second this year, after regulators received more than 50 reports of traffic violations and crashes.

Tesla also revealed its long-awaited more affordable EV models at the start of the fourth quarter. They were met with with cautious optimism by market participants. Investors will be carefully watching how these new models fare against intense price competition from domestic and foreign EV manufacturers.

Meanwhile, Tesla’s position in China continues to face pressure, with domestic manufacturer BYD Company (OTC Pink:BYDDF) surging ahead with a substantial lead. BYD delivered 582,500 pure EVs in the third quarter, nearly doubling Tesla’s China sales, which rebounded thanks to sales of the new Model Y L.

Advances in autonomous vehicle partnerships also progressed during the the third quarter, with Lyft (NASDAQ:LYFT) and Waymo collaborating on robotaxi services announced for launch next year in Nashville.

Waymo has moved to expand its user base by launching a new enterprise product, Waymo for Business, offering subsidized employee or event rides in its robotaxis in San Francisco, Los Angeles and Phoenix.

Facing rising competition, Uber Technologies (NYSE:UBER) said it plans to integrate autonomous vehicles alongside human drivers, partnering with Nuro and Lucid Group (NASDAQ:LCID) in a three part deal, with Uber purchasing 20,000 Lucid electric robotaxis over six years alongside licensing fees for Nuro’s self-driving technology.

Under the terms of the agreement, Uber will acquire minority stakes in both companies. The first robotaxis are expected to launch in a major US city next year.

Cleantech forecast for 2025

Q4 will be pivotal as the cleantech sector adjusts to the withdrawal of key federal incentives in the US, such as the rooftop solar tax credit, set to expire on December 31, and grapples with regulatory uncertainties.

Offshore wind projects face legal and administrative hurdles that may reshape regional renewable energy development.

Meanwhile, emerging areas of the cleantech market — such as advanced nuclear and climate fintech — offer promising growth paths, but require coordinated policy and investment frameworks. Reflecting this challenge, 11 states are collaborating to accelerate the development of advanced nuclear energy within their borders, seeking to create a strong and credible demand signal by coordinating commitments and dividing financial risks.

In autonomous vehicle innovation, Amazon’s (NASDAQ:AMZN) self-driving car subsidiary Zoox is seeking broader regulatory approval to operate up to 2,500 cars without traditional human controls.

If approved, Zoox would be able to conduct a first-of-its-kind paid commercial robotaxi service.

The US Department of Transportation plans to propose rules in spring 2026 to modernize vehicle safety standards for automated driving systems, including relaxing requirements tied to manual controls.

Forward-looking industry voices suggest cautious optimism, emphasizing the critical role of innovation, policy clarity and market adaptation in sustaining cleantech momentum into 2026.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how critical mineral antimony is gaining government and investor attention as its role in defense heats up, featuring Locksley Resources Ltd. (ASX: LKY,OTC:LKYRF) (OTCQX: LKYRF) (FSE: X5L), a company that specializes in critical minerals development within the United States.

Critical Mineral Antimony Stocks – Reshaping the Future of Defense

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/6292/271205_3869f824146a0bed_001full.jpg

While antimony has a wide array of uses, its contributions to national security, energy and manufacturing are currently grabbing the spotlight. The United States, Canada and the European Union have each classified it as a critical mineral, citing its essential applications in defense technologies (such as armor-piercing ammunition and explosives), energy storage systems, and electronics.

With recent news headlines that ‘United States Antimony Corporation (NYSE American: UAMY) (NYSE Texas: UAMY) Awarded $245 Million Sole-Source Five-Year Contract by the U.S. Defense Logistics Agency for the Purchase of Antimony Ingots to Replenish the U.S. National Defense Stockpile’, antimony is on a watch list globally. The stock has had a 100% gain in the past month.

Making its own headlines, Locksley Resources Ltd (ASX: LKY,OTC:LKYRF) (OTCQX: LKYRF) (FSE: X5L) just announced a significant Company milestone with the production of a 100% American made antimony ingot, marking the return of the first US domestic antimony metal production in decades.

From the news:
The milestone represents proof-of-concept for a fully American mine to-metal supply chain, from ore sourced at the Company’s Mojave Desert Antimony Mine in California, through to refining entirely within the US by Hazen Research Inc., one of the nation’s most respected metallurgical and process development laboratories.

This breakthrough directly supports US government and Presidential Executive Orders aimed at re-establishing domestic production of critical minerals vital to defense, clean energy, and strategic manufacturing supply chains. Locksley is working closely with its strategic partners, and Washington D.C based advisors, GreenMet, to advance permitting and funding initiatives to support the next stage of the Company’s commercialisation strategy.

HIGHLIGHTS

  • Locksley produces 100% American made antimony ingot from Mojave
  • Achievement validates the only known US mine-to-metal supply chain for antimony, fully independent of Chinese processing
  • Ore sourced from the Company’s Mojave Desert Antimony Mine in California and refined by Hazen Research Inc. in Colorado
  • Milestone supports US Government initiatives to secure critical minerals essential for defense, energy, and advanced manufacturing
  • Locksley is working closely with its strategic partners and Washington D.C advisors, GreenMet, to advance permitting and funding initiatives

Kerrie Matthews, Locksley CEO, commented:
‘This is a defining milestone for Locksley and the United States. The successful casting of the first 100% American made antimony ingot in decades, demonstrates mine-to-metal production is not only possible but is already underway.

‘We’ve proven the concept, and now our focus turns to scaling this achievement into a sustainable, commercial supply chain that supports America’s industrial and defense sectors. This is just the beginning, the foundation has been set, and we look forward to updating the market on the next steps for Locksley and its strategy to support America’s critical minerals independence.’

Drew Horn, CEO of GreenMet, commented:
‘Locksley’s achievement is not only a technical success, but also a national milestone. The ability to produce an American sourced and American refined antimony ingot is precisely the kind of outcome that US policymakers and industry leaders have been seeking to re-establish domestic supply chains for critical minerals.

‘GreenMet is proud to support Locksley in advancing this effort and to work alongside the Company as it progresses permitting and funding initiatives that strengthen America’s strategic materials independence.’

Validation of a 100% American Mine-to-Market Supply Chain
This achievement demonstrates Locksley’s commitment to delivering an antimony product sourced and refined entirely within the United States.

The breakthrough directly supports US government objectives to restore domestic critical mineral production. Locksley will work closely with strategic partners, including Washington, DC based advisors and GreenMet, to advance permitting and funding, supporting the next stage of the Company’s commercialisation strategy and America’s self-sufficiency in critical minerals.

Advancing Toward Pilot Scale Production
Following the successful validation of the first 100% American-made antimony ingot, Locksley Resources is now advancing towards pilot-scale production, a key step in confirming metallurgical recoveries, process efficiency, and scalability for future commercial supply.

The Company will work closely with industry partners and downstream consumers to ensure product specifications for both antimony trisulfide and antimony trioxide meet stringent US defense and industrial standards. This phase will also support offtake readiness and qualification as the leading US developer of domestically produced antimony metal.

This milestone firmly established Locksley as a pioneer in rebuilding America’s antimony supply chain, aligning with ongoing US Government and Presidential Executive Orders that prioritise domestic sourcing and processing of critical minerals essential for defense, energy storage, and advanced manufacturing.

With one of the few known high-grade, primary antimony deposits in the continental United States, the Mojave Project offers a path to scaled production and a strategic alternative to Chinese controlled supply chains, reinforcing Locksley’s role at the forefront of America’s critical minerals independence.

Strategic Context: US and Australian Government Engagement
Locksley’s milestone coincides with a significant step-up in bilateral critical minerals dialogue between the United States and Australia, underscored by Prime Minister Albanese’s upcoming meeting with President Trump in Washington, DC. Recent government briefings and funding initiatives from both nations have underscored antimony’s strategic importance and the shared objective of establishing secure, allied production capabilities.

As the first company to deliver a 100% American-made antimony ingot in decades, Locksley’s achievement positions it at the forefront of this renewed trans-Pacific strategic effort to re-establish secure, allied supply chains for critical minerals, vital to defense, energy, and advanced manufacturing.

Next Steps
With proof-of-concept successfully achieved, Locksley is now transitioning from validation to pilot-scale and pre-commercial operations in the United States. The next phase of work will focus on scaling, refining, and positioning the Company for government and industry engagement:

  • Scale-up to U.S based pilot plant operations: Establishing a domestic pilot facility to validate process efficiency, recoveries, and repeatability under commercial conditions.
  • Detailed metallurgical interpretation and process flow-sheet optimisation: Utilise test data from Hazen Research to refine processing parameters and finalise design inputs for larger scale operations.
  • Engagement with U.S. government and industrial partners: Advance discussions for offtake qualification, funding support, and strategic collaboration under existing national interest programs and defense supply chain programs.
  • Commercial pathway planning: Progress engineering, permitting, and funding initiatives in collaboration with Washington D.C-based advisors GreenMet, as Locksley advances towards establishing a fully integrated, American controlled antimony production and processing capability.

Following the news, the Sydney Morning Herald reported, ‘Locksley Resources has just etched its name into United States industrial history by pouring the first fully American-made antimony ingot in almost 10 years, placing the ASX-listed junior squarely in Washington’s headlights as the country pushes for critical mineral self-sufficiency.’

Looking at recent news from United States Antimony Corporation (NYSE American: UAMY) (NYSE Texas: UAMY), the Company just announced they submitted a confidential, non-binding, indicative proposal to acquire 100% of the share capital of Larvotto Resources Limited by way of a scheme of arrangement under the Australian Corporations Act 2001.

From the news:
Under the Proposal, Larvotto shareholders would receive Six (6) USAC shares for every One Hundred (100) Larvotto shares which represents a significant premium to (i) Larvotto’s last equity capital raise announced on 25 July 2025 (ii) recent stock trading price ranges. The terms of the proposed transaction are subject to the negotiation and execution of a binding scheme implementation deed, Larvotto shareholder approval, regulatory approvals and customary closing conditions.

USAC has recently acquired approximately 10.0% of Larvotto’s total issued share capital with cash in the open market which USAC believes makes USAC Larvotto’s largest single shareholder.

Another Australian dual listed antimony stock, Nova Minerals Limited (NASDAQ: NVA) (ASX: NVA) (FSE: QM3), turned heads in the sector when it announced recently that its 100% owned US subsidiary Alaska Range Resources, LLC (ARR), had been awarded US$43.4 million in Defense Production Act Title III funding by the US Department of War (DoW) to produce antimony trisulfide at its Estelle Gold and Critical Minerals Project (Estelle Project) in Alaska.

From the news:
The award will enable ARR to accelerate development of a fully integrated US antimony supply chain to extract, concentrate, and refine stibnite to produce military grade antimony trisulfide to assist in meeting the US defense industrial base demands.

Nova CEO, Mr. Christopher Gerteisen, commented: ‘We are proud to have ARR partner with the U.S. Department of War to help secure a fully domestic, redundant supply chain for the munitions and other defense products our troops need to keep our nation and allies safe, as well as future supply to the US industrial base for a wide range of traditional and high-tech applications, including semiconductors and energy systems.

‘This award will fund the initial phase of the Company’s strategy to establish a full spectrum state of the art antimony mining and refining hub based in Alaska to supply refined antimony products to the US industrial base and beyond. After conducting rigorous vetting and technical due diligence of the Estelle Project, ARR is proud to be the recipient of this award, which provides further confidence in the quality of antimony mineralization and highlights the potential scale and scope of future antimony production from the Estelle Project.’

Following Nova’s news, Locksley Resources (ASX: LKY,OTC:LKYRF) (OTCQX: LKYRF) announced that the company’s advancing metallurgical test work program being conducted on surface samples collected from the Desert Antimony Mine (DAM) Prospect at the company’s project in the Mojave Desert is producing concentrate grades believed to be significantly higher than comparable American projects (as reported in publicly available information from Perpetua (NASDAQ: PPTA) (TSX: PPTA), Nova Minerals (NASDAQ: NVA), US Antimony Corp (NYSE American: UAMY), Costerfield and Hillgrove.

From the news:
According to early results, excellent high grade final flotation concentrate of 68.1% antimony has been achieved from first pass rougher/regrind/cleaner flotation tests. The concentrate is 95% of technical maximum stibnite grade of 71.68% showing minimal impurities, significantly exceeding marketable sales requirements of a minimum of 55%.

Research more mining stocks with Investorideas.com free stock directory
https://www.investorideas.com/Gold_Stocks/stocks_list.asp

About Investorideas.com – Big Investing Ideas
Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

Disclaimer/Disclosure: Locksley Resources Limited is a paid featured mining stock on Investor ideas. This is not investment opinion. Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact management and IR of each company directly regarding specific questions. More disclaimer and disclosure info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Follow us on X @investorideas @stocknewsbites
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com
800 665 0411

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271205

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

  • MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA.

  • New data from the ARCHER trial, highlighting the magnitude of reduction in left ventricular (LV) mass and the read through to heart failure, to be presented at a cardiology conference in November 2025.

  • Next-generation therapy CRD-38 for heart failure funded through to clinical development, with partnership discussions advancing with leading pharmaceutical companies.

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (‘Cardiol’ or the ‘Company’), a clinical-stage life sciences company advancing late-stage, anti-inflammatory and anti-fibrotic therapies for heart disease, today announced the successful completion of the previously announced private placement offering (the ‘Offering’) of units (‘Units’) for total proceeds of US$11.4 million, reflecting closing on all funds previously committed under the Offering.

‘As recruitment in our pivotal Phase III MAVERIC trial gains momentum, with several prominent centers across the U.S. now enrolling patients, we are pleased to have secured a direct investment of US$11.4 million to strengthen our balance sheet and accelerate the development of our novel heart failure drug, CRD-38, based on the recently reported findings from our ARCHER trial,’ said David Elsley, President and CEO of Cardiol Therapeutics. ‘Topline results from our ARCHER trial demonstrated a significant reduction in LV mass-marking the first evidence of structural and remodeling improvement in patients with myocarditis. This landmark finding represents our second clinical validation in inflammatory heart disease and establishes a key translational link to data published earlier this year in the Journal of the American College of Cardiology, which demonstrated the beneficial effects of the active pharmaceutical ingredient or API in CardiolRx on cardiac structure, inflammation, and fibrosis in a model of heart failure. The ARCHER findings support pursuing an additional Orphan Drug Designation for CardiolRx in myocarditis and advancing the development of our next-generation CRD-38 formulation, which delivers the same API via subcutaneous administration, to target the broader heart failure market. Notably, blockbuster drugs that reduce LV mass have been shown to lower heart failure-related death and hospitalization, underscoring the clinical potential of Cardiol’s differentiated anti-inflammatory mechanism to address a large unmet need in heart failure, where five-year mortality rates still exceed 50%.’

Under the Offering, the Company sold a total of 11.4 million Units at a price of US$1.00 per Unit. Each Unit consists of one Class A common share of the Company (a ‘Common Share‘) and one-half of one Common Share purchase warrant. Each whole warrant entitles the holder to acquire one additional Common Share at an exercise price of US$1.35 for a period of 24 months from the date of issuance. The warrants include an acceleration provision, allowing the Company to advance their expiry to the 30th day following the issuance of a news release if the daily volume-weighted average trading price of the Common Shares exceeds US$2.00 for five consecutive trading days. Proceeds from the Offering provide cash resources that are anticipated to support operations into the third quarter of 2027.

The securities have not been registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any U.S. state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the ‘United States’ or ‘U.S. persons’ (as such terms are used in Regulation S under the U.S. Securities Act), absent registration under the U.S. Securities Act and all applicable U.S. state securities laws or in compliance with an exemption therefrom. This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

Certain insiders of the Company participated in the Offering. Such participation is considered to be a ‘related-party transaction’ within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (‘MI 61-101‘). The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related-party participation in the Offering as the fair market value (as determined under MI 61-101) of the subject matter of, and the fair market value of the consideration for, the transaction, insofar as it involved interested parties, did not exceed 25% of the Company’s market capitalization (as determined under MI 61-101).

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company advancing late-stage, anti-inflammatory and anti-fibrotic therapies for heart disease. The Company’s lead small molecule drug candidate, CardiolRx, modulates inflammasome pathway activation, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with pericarditis, myocarditis, and heart failure.

The MAVERIC Program in recurrent pericarditis, an inflammatory disease of the pericardium which is associated with symptoms including debilitating chest pain, shortness of breath, and fatigue, and results in physical limitations, reduced quality of life, emergency department visits, and hospitalizations, comprises the completed Phase II MAvERIC-Pilot study (NCT05494788) and the ongoing pivotal Phase III MAVERIC trial (NCT06708299). The U.S. FDA has granted Orphan Drug Designation to CardiolRx for the treatment of pericarditis, which includes recurrent pericarditis.

The ARCHER Program (NCT05180240) comprises the completed Phase II study in acute myocarditis, an important cause of acute and fulminant heart failure in young adults and a leading cause of sudden cardiac death in people less than 35 years of age.

Cardiol is also developing CRD-38, a novel subcutaneously administered drug formulation intended for use in heart failure-a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding US$30 billion annually.

For more information about Cardiol Therapeutics, please visit cardiolrx.com.

Cautionary statement regarding forward-looking information:

This news release contains ‘forward-looking information’ within the meaning of applicable securities laws. All statements, other than statements of historical fact, that address activities, events, or developments that Cardiol believes, expects, or anticipates will, may, could, or might occur in the future are ‘forward-looking information’. Forward looking information contained herein may include, but is not limited to statements regarding the Company’s focus on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, the Company’s intended clinical studies and trial activities and timelines associated with such activities, including the Company’s plan to complete the Phase III study in recurrent pericarditis with CardiolRx, the Company’s plan to advance the development of CRD-38, a novel subcutaneous formulation intended for use in heart failure, the Company’s presentation and publication of the comprehensive ARCHER trial data, the Company’s belief that results from the ARCHER trial provide compelling clinical proof of concept for CardiolRx and strongly support advancing the clinical development of CardiolRx and CRD-38 for the treatment of inflammatory cardiac disorders including cardiomyopathies, heart failure, and myocarditis, and statements regarding the expected length and scope of funding for the Company’s development plans as a result of the Offering. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is based on certain assumptions and is also subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward looking information, and are not (and should not be considered to be) guarantees of future performance. These risks and uncertainties and other factors include the risks and uncertainties referred to in the Company’s Annual Information Form filed with the Canadian securities administrators and U.S. Securities and Exchange Commission on March 31, 2025, available on SEDAR+ at sedarplus.ca and EDGAR at sec.gov, as well as the risks and uncertainties associated with product commercialization and clinical studies. These assumptions, risks, uncertainties, and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information, and such information may not be appropriate for other purposes. Any forward-looking information speaks only as of the date of this press release and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events, or results, or otherwise. Investors are cautioned not to rely on these forward-looking statements.

For further information, please contact:
Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271249

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce the third batch of results from the fully funded 100,000-m drilling program (2 drill rigs) for the Contact Sector and more precisely, the North Contact Zone (NCZ), on its 100%-owned Cadillac Project, located in Val-d’Or (Abitibi, Quebec). The NCZ consists of three parallel high-grade gold zones: NCZ (1), NCZ (2) and NCZ (3).

Strategic Highlights from Contact Sector

Drill Results of NCZ (Figures 1 & 2)

  • NCZ (3) intersected in hole CA25-530 graded 30.2 g/t Au over 2.5 m included in 11.0 g/t Au over 9.0 m with presence of visible gold grains , at a depth of 270 m, hole CA25-527 reported 27.1 g/t Au over 1.0 m included in 2.2 g/t Au over 18.0 m at a depth of 325 m and hole CA25-529 cut 6.1 g/t Au over 1.0 m included in 4.3 g/t Au over 4.0 m at a depth of 215 m.
  • NCZ (1) intersected in hole CA25-526 graded 11.7 g/t Au over 0.5 m , at a depth of 230 m and hole CA25-530 reported 10.4 g/t Au over 0.5 m with presence of visible gold grains, at a depth of 200 m.
  • NCZ (1) and NCZ (3) are spaced approximately 50 m apart.

Significance for Investors

  • Holes CA25-526, CA25-527, CA25-529 and CA25-530 continue to clearly demonstrate the presence of a shallow and extensive mineralized system, hosting multiple high-grade gold zones with significant grades and widths . The mineralization has now been extended over 400 m in strike length by 300 m in depth , remains open in all directions , suggesting significant expansion potential .
  • These latest assay results follow up on previously reported intercepts, including 16.7 g/t Au over 2.1 m within a broader interval of 5.9 g/t Au over 7.7 m (hole CA25-524) and 4.3 g/t Au over 2.0 m (hole CA25-525), as disclosed in Cartier’s September 23, 2025 news release titled ″ Cartier Cuts 16.7 g/t Au over 2.1 m at Contact (Cadillac); Strengthens Shallow High-Grade Gold Potential; Supports Expansion Drilling. ″
  • The combination of exposed bedrock , minimal overburden (less than 5 m) and proximity to year-round road access (within 250 m) positions NCZ as a highly strategic asset for potential shallow operation scenarios . These logistical advantages should significantly enhance the development flexibility and economics of the Cadillac Project.

Next Steps

  • Additional drilling is required on NCZ to confirm geological continuity , expand gold mineralization (150-300 m), extend footprint closer to surface (0-150 m) and advance toward a future gold inventory .
  • Further exploration drilling is already planned to test several new high-priority regional targets at Contact Sector, backed by detailed structural and geological modelling and VRIFY’s artificial intelligence (AI) driven targeting , reinforcing the potential for additional gold discoveries .

This second set of high-grade gold results in the Contact Sector is extremely encouraging for the long-term potential of the Cadillac Project. The decision to allocate part of the 100,000-m drill program to this sector is clearly delivering strong results for our shareholders. These outcomes reflect our focused strategy of advancing known mineralized zones while also targeting high-priority regional exploration opportunities .’ – Philippe Cloutier, President and CEO of Cartier.

The updated geological model, from continuous analysis and interpretation of results, is yielding positive results and highlighting the significant potential of the Contact Sector. Improved understanding of the structural features is allowing us to more efficiently and accurately target mineralized zones. The gold potential of the Héva Fault Zone, hosting NCZ, remains largely underexplored and we believe there is significant upside yet to be unlocked. ‘ – Ronan Deroff, Vice President Exploration of Cartier.

Figure 1 : Plan view, cross and long sections of the Contact Sector

Figure 2 : Photos of the drill core from hole CA25-530

Table 1 : Drill hole best assay results from Contact Sector

Hole Number From (m) To (m) Core Length** (m) Au (g/t) Uncut Vertical Depth (m) Zone
CA25-526 239.0 239.5 0.5 11.7 ≈230 North Contact (1)
And 277.1 282.1 5.0 1.1 ≈270 North Contact (2)
CA25-527 252.0 262.0 10.0 1.0 ≈250 North Contact (2)
And 322.0 340.0 18.0 2.2 ≈325 North Contact (3)
Including 339.0 340.0 1.0 27.0
CA25-528 194.0 205.0 11.0 1.0* ≈160 North Contact (3)
CA25-529 151.0 152.0 1.0 6.2 ≈135 North Contact (1)
And 237.0 241.0 4.0 4.3 ≈215 North Contact (3)
Including 240.0 241.0 1.0 6.1
CA25-530 209.0 209.5 0.5 10.4* ≈200 North Contact (1)
And 280.0 289.0 9.0 11.0* ≈270 North Contact (3)
Including 282.0 284.5 2.5 30.2*

* Occurrences of visible gold (VG) have been noted in the drill core at various intervals. ** Based on the observed intercept angles within the drill core, true thicknesses are estimated to represent approximately 50–85 % of the reported core length intervals.

Contact Sector

The Contact Sector is a highly prospective area featuring the North Contact Zone (‘NCZ’) and several newly defined high-priority drill targets.

The NCZ lies along an east-west trending, strongly sheared corridor (Héva Fault Zone), situated approximately 900 m north of the Cadillac Fault Zone, and occurs at the contact between the hanging wall mafic to intermediate volcanics (basalt to andesite) of Louvicourt Group and the footwall turbiditic sedimentary rocks (wacke-mudrock) of Cadillac Group. This lithological contact is a favorable horizon for hydrothermal fluid flow, likely related to synvolcanic gold deposition.

The NCZ, defined by at least three parallel gold-rich zones, are typically and primarily associated with a fine-grained and disseminated arsenopyrite-pyrrhotite mineralization, with a pervasive biotite-chlorite-carbonate alteration, all crosscut by late-stage smoky quartz vein and veinlet stockworks containing visible gold. Locally, accessory minerals such as sphalerite, galena and tourmaline are observed.

Milestones of 2025-2027 Exploration Program

100,000 m Drilling Program (Q3 2025 to Q2 2027)

The ambitious 600-hole drilling program will both expand known gold zones (Brownfield Growth) and test new shallow surface high-potential targets (Greenfield Discovery). The objective is to unlock the camp-scale, high-grade gold potential along the 15 km Cadillac Fault Zone. It is important to note that Cartier’s recent consolidation of this large land holding offers the unique opportunity in over 90 years for unrestricted exploration.

Environmental Baseline Studies & Economic Evaluation of Chimo mine tailings (Q3 2025 to Q3 2026)

The baseline studies will be divided into two distinct parts which include 1) environmental baseline desktop study and 2) preliminary environmental geochemical characterization. The initial baseline studies will provide a comprehensive understanding of the current environmental conditions and implement operations that minimize environmental impact while optimizing the economic potential of the project. These studies will be supplemented by an initial assessment of the economic potential of the past-producing Chimo mine tailings to determine whether a quantity of gold can be extracted economically.

Metallurgical Sampling and Testwork Program (Q4 2025 to Q1 2026)

The metallurgical testwork program includes defining of expected gold recovery rates and improving historical results from the Chimo deposit, as well as establishing metallurgical recovery data for the first-time for the East Chimo and West Nordeau satellite deposits, where no previous data exists. This comprehensive program will characterize the mineralized material, gold recovery potential and validate optimal grind size defining the most efficient and cost-effective flowsheet. The data generated will directly support optimized project development and have the potential to significantly reduce both capital and operating costs, while also improving the environmental footprint.

Table 2 : Drill hole collar coordinates from Contact Sector

Hole Number UTM Easting (m) UTM Northing (m) Elevation (m) Azimuth (°) Dip (°) Hole Length (m)
CA25-526 335670 5320160 364 228 -76 392
CA25-527 335670 5320160 364 198 -81 384
CA25-528 335729 5320155 363 186 -55 240
CA25-529 335729 5320155 363 197 -66 270
CA25-530 335729 5320155 363 198 -74 316

Table 3 : Drill hole detailed assay results from Contact Sector

Hole Number From (m) To (m) Core Length* (m) Au (g/t) Uncut Vertical Depth (m) Zone
CA25-526 220.0 221.0 1.0 1.3 ≈210 North Contact (1)
And 233.0 234.0 1.0 1.3 ≈230
And 234.5 235.0 0.5 1.2
And 239.0 239.5 0.5 11.7
And 277.1 282.1 5.0 1.1 ≈270 North Contact (2)
Including 277.1 278.1 1.0 1.4
Including 279.1 280.1 1.0 1.6
Including 280.1 281.1 1.0 1.2
Including 281.1 282.1 1.0 1.0
And 330.0 331.0 1.0 4.0 ≈320

North Contact (3)

And 331.0 332.0 1.0 1.6
CA25-527 252.0 262.0 10.0 1.0 ≈250 North Contact (2)
Including 252.0 253.0 1.0 2.1
Including 253.0 254.0 1.0 1.0
Including 255.0 256.0 1.0 1.1
Including 261.0 262.0 1.0 2.1
And 272.0 273.0 1.0 3.7 ≈265
And 282.0 283.0 1.0 1.3 ≈275
And 322.0 340.0 18.0 2.2 ≈325 North Contact (3)
Including 322.0 323.0 1.0 2.9
Including 324.0 325.0 1.0 2.4
Including 325.0 326.0 1.0 5.8
Including 339.0 340.0 1.0 27.0
CA25-528 194.0 205.0 11.0 1.0* ≈160 North Contact (3)

Including 195.0 196.0 1.0 2.4
Including 197.0 198.0 1.0 2.7
Including 201.5 202.5 1.0 1.7*
Including 204.0 205.0 1.0 1.8
CA25-529 151.0 152.0 1.0 6.2 ≈135 North Contact (1)

And 237.0 241.0 4.0 4.3 ≈215 North Contact (3)

Including 237.0 238.0 1.0 3.8
Including 238.0 239.0 1.0 4.2
Including 239.0 240.0 1.0 3.1
Including 240.0 241.0 1.0 6.1
And 242.0 243.0 1.0 1.2
And 253.0 254.0 1.0 2.0 ≈225
CA25-530 209.0 209.5 0.5 10.4* ≈200 North Contact (1)

And 223.5 224.5 1.0 1.3 ≈210 North Contact (2)

And 280.0 289.0 9.0 11.0* ≈270 North Contact (3)
Including 2800 281.0 1.0 1.9
Including 281.0 282.0 1.0 2.6
Including 282.0 283.0 1.0 9.4
Including 283.0 284.0 1.0 62.9
Including 284.0 284.5 1.0 6.6*
Including 284.5 285.0 1.0 2.0
Including 285.0 286.0 1.0 2.6
Including 286.0 287.0 1.0 1.4
Including 288.0 289.0 1.0 13.4
And 295.0 296.0 1.0 1.9

* Occurrences of visible gold (VG) have been noted in the drill core at various intervals. ** Based on the observed intercept angles within the drill core, true thicknesses are estimated to represent approximately 50–85 % of the reported core length intervals.

Quality Assurance and Quality Control (QA/QC) Program

The drill core from the Cadillac Project is NQ-size and, upon receipt from the drill rig, is described and sampled by Cartier geologists. Core is sawn in half, with one half labelled, bagged and submitted for analysis and the other half retained and stored at Cartier’s coreshack facilities located in Val-d’Or, Quebec, for future reference and verification. As part of Quality Assurance and Quality Control (QA/QC) program, Cartier inserts blank samples and certified reference materials (standards) at regular intervals into the sample stream prior to shipment to monitor laboratory performance and analytical accuracy.

Drill core samples are sent to MSALABS’s analytical laboratory located in Val-d’Or, Quebec, for preparation and gold analysis. The entire sample is dried and crushed (70% passing a 2-millimeter sieve). The analysis for gold is performed on an approximately 500 g aliquot using Chrysos Photon Assay technology, which uses high-energy X-ray excitation with gamma detection to quickly and non-destructively measure gold content.

Alternatively, samples are submitted to Activation Laboratories Ltd. (‘Actlabs’), located in either Val-d’Or or Ste-Germaine-Boulé, both in Quebec, for preparation and gold analysis. The entire sample is dried, crushed (90% passing a 2-millimetre sieve) and 250 g is pulverized (90% passing a 0.07-millimetre sieve). The analysis for gold is conducted using a 50 g fire assay fusion with atomic absorption spectroscopy (AAS) finish, with a detection limit up to 10,000 ppb. Samples exceeding this threshold are reanalyzed by fire assay with a gravimetric finish to determine high-grade values accurately.

Both MSALABS and Actlabs are ISO/IEC 17025 accredited for gold assays and implement industry-standard QA/QC protocols. Their internal quality control programs include the use of blanks, duplicates, and certified reference materials at set intervals, with established acceptance criteria to ensure data integrity and analytical precision.

Qualified Person

The scientific and technical content of this press release has been prepared, reviewed and approved by Mr. Ronan Déroff, P.Geo., M.Sc., Vice President Exploration, who is a ″Qualified Person″ as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (″NI 43-101″).

About Cadillac Project

The Cadillac Project, covering 14,000 hectares along a 15-kilometre stretch of the Cadillac Fault, is one of the largest consolidated land packages in the Val-d’Or mining camp. Cartier’s flagship asset integrates the historic Chimo Mine and East Cadillac projects, creating a dominant position in a world class gold mining district. With excellent road access, year-round infrastructure and nearby milling capacity, the project is ideally positioned for rapid advancement and value creation.

Using a gold price of US$1,750/oz, a Preliminary Economic Assessment demonstrated the economic viability of a 2-km segment, compared to the 15 km that will be the subject of the 100,000 m drilling program, with an average annual gold production of 116,900 oz over a 9.7-year mine life. Indicated resources are estimated at 720,000 ounces (7.1 million tonnes at 3.1 g/t Au) and inferred resources at 1,633,000 ounces (18.5 million tonnes at 2.8 g/t Au). Please see the NI 43-101 ″Technical Report and Preliminary Economic Assessment for Chimo Mine and West Nordeau Gold Deposits, Chimo Mine and East Cadillac Properties, Quebec, Canada, Marc R. Beauvais, P.Eng., of InnovExplo Inc., Mr. Florent Baril of Bumigeme and Mr. Eric Sellars, P.Eng. of Responsible Mining Solutions″ effective May 29, 2023.

About Cartier Resources Inc.

Cartier Resources Inc., founded in 2006 and headquartered in Val-d’Or (Quebec) is a gold exploration company focused on building shareholder value through discovery and development in one of Canada’s most prolific mining camps. The Company combines strong technical expertise, a track record of successful exploration, and a fully funded program to advance its flagship Cadillac Project. Cartier’s strategy is clear: unlock the full potential of one of the largest undeveloped gold landholdings in Quebec.

For further information, contact:
Philippe Cloutier, P. Geo.
President and CEO
Telephone: 819-856-0512
philippe.cloutier@ressourcescartier.com
www.ressourcescartier.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/4c94767e-126a-4d86-8ce2-0a4661805df7

https://www.globenewswire.com/NewsRoom/AttachmentNg/da3b89aa-ecc3-46c7-97e0-67013c6dea9c

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com

United States Antimony (NYSE:UAMY) said on Sunday (October 19) that it is proposing to acquire Australian company Larvotto Resources (ASX:LRV).

In a takeover offer, USAC said that it would pay AU$1.40 per Larvotto share, a 12.9 percent premium to the stock’s last close.

Larvotto shareholders are set to receive six USAC shares for every 100 Larvotto shares held, bringing Larvotto’s value to AU$722.9 million.

Prior to this, USAC already secured approximately 10 percent of Larvotto’s total issued share capital, believing it is currently the company’s largest single shareholder. The acquisition forms part of USAC’s goal to become a major antimony producer.

Larvotto owns the dual-commodity Hillgrove antimony-gold project in New South Wales, which is expected to become Australia’s largest antimony producer.

Hillgrove is projected to produce about 7 percent of global antimony supply. It currently holds a mineral resource of 1.7 million ounces gold equivalent at 7.4 grams per tonne gold equivalent.

The project is scheduled to commence production in 2026.

‘Our proposal to combine with Larvotto reflects our deep commitment to build a world-class industry player in the critical minerals space and our strong conviction in the strategic and cultural fit between the two organizations as well as our countries,” commented USAC Chairman and Chief Executive Officer Gary C. Evans.

In a separate announcement, Larvotto confirmed receipt of the offer, saying that it is subject to certain conditions and will be “carefully considered” by the board.

Shares of Larvotto saw a spike following this announcement, closing at AU$1.295 on Monday (October 20). This represents a 4.44 percent increase from its Friday close of AU$1.240.

Securities Disclosure: I, Gabrielle de la Cruz, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

In the spring of 2022, Canadian teenager Markus Schouten’s dying wish was that no child should be forced to choose between life and death.

Markus had just learned he was about to die. His oncologist broke the news to him and his family on the eighth floor cancer ward at British Columbia Children’s Hospital in Vancouver, Canada. They held each other, weeping.

Weeks later, lying on his family’s living room sofa, Markus dictated a letter to the Canadian Parliament’s Special Joint Committee on Medical Assistance in Dying, established to set guidelines on a federal law that allowed ‘assisted suicide’ in Canada in 2016.

Markus opposed lobbying efforts to expand the law to children under the age of 18.

‘That’s because life is worth living and we should always work to alleviate suffering without eliminating the sufferer,’ read the final letter, which was signed by his parents.

The letter closed, ‘Life is worth living, even when we are dying.’ 

A month later, Markus died, surrounded by his family and friends, telling them, ‘See you in paradise.’ 

Three years later, his parents, Mike and Jennifer Schouten, are carrying the torch for Markus in a mission to block efforts to allow ‘mature minors’ the right to choose to die through assisted suicide. They now work alongside a global network of like-minded advocates, including disability rights groups, who argue the assisted-suicide industry targets vulnerable people who would benefit from assisted living services. Already, in Canada, the law is expected to expand to patients with severe psychiatric disorders, as early as 2027.

But they are up against a powerful, well-funded machine. A Fox Digital investigation reveals the Schoutens and other opponents of euthanasia face a multimillion-dollar global lobby that could be called Assisted Suicide Inc., a sprawling network changing laws worldwide, developing euthanasia services for funeral parlors, selling ‘suicide pods,’ promoting ‘suicide tourism’ and even training ‘doulas for death.’

‘As we continue to expand the euthanasia regime, all the safeguards and windows have gone out the window,’ said Mike Schouten. ‘And it becomes open season for anyone to choose death, including children.’

What began as a limited effort to provide adults with terminal illnesses the ability to end pain and suffering has now grown into an international industry. According to a database compiled by the Pearl Project, a nonprofit journalism initiative, at least 96 organizations worldwide are now part of this movement. 

The global lobby cloaks assisted suicide in the language of civil rights and human rights, using euphemisms in their names, such as ‘assisted dying,’ ‘medical assistance in dying,’ ‘dying with dignity,’ ‘choice,’ ‘end of life,’ ‘completed life,’ ‘final exit,’ ‘free exit’ and the ‘right to die.’

These groups have a presence on every continent, but are predominately found in the West, which also faces alarmingly low birth rates. There are 41 groups in Europe; 31 groups in North America, with 25 of them in the United States, four in Canada and two in Mexico; 13 in Oceania, with most in Australia and one in New Zealand; and only five in Asia, two in Africa, and three in South America.

While most of their work has focused on adults, with Robert Munsch, the Canadian author of the best-selling children’s book, ‘Love You Forever,’ the latest high-profile person to recently announce he was approved for assisted suicide after being diagnosed with dementia. ‘Hello, Doc — come kill me!’ he joked, sharing the news.

The boundaries are shifting. Behind the push to extend these laws to children lies a legal Trojan horse: the ‘mature minor doctrine.’

This concept, first established in a 1967 Washington Supreme Court case, Smith v. Seiblyonce allowed limited medical discretion for minors. But over decades, it has metastasized into a sweeping jurisdiction for granting children autonomy – and secrecy – over their medical decisions. Today, it lets minors make choices without parental involvement on gender pronouns, gender transitions, contraception and abortion. In 13 U.S. states and the District of Columbia, minors can even obtain abortions without parental knowledge.

Now, advocates are leveraging that same doctrine to argue that children should have the ‘medical autonomy’ to choose death. The ‘National Youth Rights Association,’ a 501(c)(3) nonprofit based in Hyattsville, Md., uses the ‘mature minors’ to die by physician-assisted suicide.

Euthanasia is already legal for adults in Australia, Belgium, Colombia, the Netherlands, New Zealand, Spain and 11 U.S. states. But three countries – the Netherlands, Belgium and Colombia – have gone further, allowing ‘mature minors’ to die by physician-assisted suicide.

In February 2023, despite the pleas of Marcus and his parents, Canada’s Special Joint Committee on Medical Assistance in Dying recommended extending the right to some youth, declaring that parents should be ‘consulted’ but that the ‘will of a minor’ with decision-making capacity ‘ultimately takes priority.’

The same debate has now reached the United Kingdom, where a bill to allow adult euthanasia is moving through the British Parliament. Earlier this year, the British House of Commons narrowly voted 259 to 216 to bar physicians from discussing assisted suicide with youth, meaning nearly half of lawmakers supported discussing assisted suicide for youth.

Katharine Birbalsingh, a British educator known as ‘Britain’s Strictest Headmistress,’ believes it’s only a matter of time before youth are included.

‘Assisted suicide will spread, full stop,’ she told Fox Digital. ‘And the people allowed to do assisted suicide will grow, making it younger and younger.’

Birbalsingh argues that Western societies have fallen for the dangerous illusion that ‘the child must lead,’ leading to thinking such as ‘Oh, he wants to change his gender, or he wants to commit suicide.’

‘Once upon a time,’ she said, ‘adults used to say, ‘No, the child is not capable of leading, because he is a child.‘ In the West, we have forgotten that we’re meant to be in charge as adults.’

‘There ‘s just a million reasons why young people would want to choose death,’ said Birbalsingh, the founder of the Michaela Community School in London. ‘You know, young people are compulsive, they make whimsical decisions. They make irresponsible decisions. They’re young. That’s sort of the definition of a child.’

‘That’s why they need looking after,’ Birbalsingh added. ‘That’s why we need to look after them as adults. That’s our job. It’s our role in life, to keep and protect them, sometimes from themselves. The people making these decisions just don’t understand young people.’ Lawmakers there was a ‘very real risk’ that proposed assisted suicide legislation, called the ‘Terminally Ill Adults (End of Life) Bill,’ would be expanded to include children if they didn’t vote for her amendment.

British Labour Party MP Meg Hillier voiced similar concerns during parliamentary debate, warning that teen brains make them particularly ‘susceptible to being influenced, including into dangerous and risky behavior.’

She said, ‘In a number of countries, assisted dying laws have been expanded to allow children and young people to end their lives. We need to be alert to that very real risk.’

Another MP, Sorcha Eastwood, cited social media’s toll on youth brain health, saying, ‘If we throw this into the mix, it has the potential to do untold damage.’

So far, pro-euthanasia groups in the U.S. have remained quiet about extending assisted suicide to minors, but critics fear it’s only a matter of time.

The British Children’s Commissioner, Dame Rachel de Souza, warned that the proposed changes would allow doctors to discuss assisted dying with 17-year-olds ‘deemed competent,’ preparing them for the choice upon turning 18. In a May report, she said that she had convened a panel of youth to discuss the issue.

In Canada, the euphemism ‘MAID,’ or ‘Medical Assistance In Dying,’ has softened the conversation. But the statistics are stark. In 2023, about 15,000 Canadians died through ‘MAID,’ about one in every 20 deaths nationwide, a 16% increase from 2022, making assisted suicide the fifth leading cause of death. 

The movement is also big business. Dying with Dignity Canada, based in Toronto, reported $3 billion in expenses in 2024, including $803,555 for advertising and promotions. It publicly argues that ‘mature minors should be allowed the right to choose MAID,’ calling it ‘unfair’ to deny a 17-year-old what a 70-year-old is granted.

The British Columbia Humanist Association, the Canada chapter of Humanists International Inc., a 501(c)(3) nonprofit based in New York City, likewise demands MAID access for ‘mature minors’ and ‘those whose sole underlying condition is a mental illness,’ It insisting there is ‘no moral or ethical distinction between a mature minor and a young adult.’ It argues: ‘Ensure Dignity in Death.’ The ‘high priestess’ of euthanisia, Dr. Ellen Wiebe, also supports extending assisted suicide to children. 

The Netherlands offers a preview of what comes next. Legal since 2002, Dutch euthanasia laws permit doctors to end lives of children as young as one, including newborns ‘suffering unbearably with no prospects of improvement.’ 

By 2024, euthanasia accounted for 9,958 deaths in 2024, or 5.8% of the country’s deaths.

A recent study published in the International Journal of Psychiatry found that among Dutch euthanasia applicants, 73% were young women with psychiatric diagnoses including major depression, autism, eating disorder, trauma-related disorders and a ‘history of suicidality.’ The researchers acknowledged there is an ‘urgent need’ to study ‘persistent death wishes’ in this ‘high-risk group.’

In one chilling case, a boy with autism, aged 16 to 18, ended his life after describing it as ‘joyless’ and ‘lonely,’ according to the 2024 annual report of the Regional Euthanasia Review Committees, which approves medical-assisted suicides. His doctor ‘had no doubt about his decisional competence.’

Last year, 14 Dutch psychiatrists urged prosecutors to investigate a case involving a 17-year-old girl, Milou, who died by euthanasia after years of depression, anxiety and suicidal ideation, following childhood sexual abuse. They warned against the ‘widespread promotion of euthanasia’ leading to ‘unnecessary deaths.’ The Royal Dutch Medical Association scolded the psychiatrists, and prosecutors declined to act.

In 2014, Belgium became the second country in the world to allow child euthanasia, requiring parental consent.The Belgian Federal Euthanasia Review and Evaluation Committee says that six youth have requested euthanasia between 2014 and 2024. Last year, one young person made the request. 

The industry has faced allegedly criminal revelations. In Australia, one alleged ‘euthanasia ring kingpin,’ Brett Daniel Taylor, faces prison for selling vulnerable people lethal veterinary drugs nicknamed ‘the Green Dream.’

Back in Canada, Mike and Jennifer Schouten remain committed to fulfilling their son’s wish. 

Michael remembers Markus lying on the sofa, dictating the words that became his son’s final message to lawmakers.

One day, in his final days, Markus said to his parents, ‘I can see what you are doing with your work is connected to what we’re going through. If we can share our story, we should.’

Now, Michael says, ‘I feel he is blessing our work.’

This story discusses suicide. If you or someone you know is having thoughts of suicide, please contact the Suicide & Crisis Lifeline at 988 or 1-800-273-TALK (8255).

This post appeared first on FOX NEWS

Two Israel Defense Forces (IDF) soldiers were killed by terror operatives in Rafah, southern Gaza, threatening the ceasefire with Hamas, Israeli military sources confirmed to Fox News Digital on Sunday.

The soldiers, Major Yaniv Kula, 26, a company commander in the 932nd Battalion of the Nahal Brigade, and Staff Sergeant Itay Yavetz, 21, a combat soldier in the same battalion, were both based in Modi’in-Maccabim-Reut.

According to the initial IDF investigation, a militant cell had emerged from a tunnel and fired at an excavation vehicle, killing the two soldiers. A reserve soldier was also severely wounded and evacuated to a hospital, per The Times of Israel.

According to Professor Kobi Michael, senior researcher at the Institute for National Security Studies (INSS) and the Misgav Institute, the attack showed the fragility of the ceasefire deal.

‘Today’s violation of the agreement was severe,’ Michael said. ‘I assume that this is not going to be the last one,’ he told Fox News Digital.

‘Israel complies [with President Trump’s] plan and wants to continue with the realization of the plan,’ he said.

‘This agreement was violated since the first day by Hamas,’ Michael added. ‘And it continued with their behavior with regard to the hostages, the dead hostages.’

‘All the manipulation that they are doing plays on the nerves of Israeli society,’ he continued, saying the terror group is ‘making themselves as if they are not able… to find the bodies where everybody knows that they can.’

Michael detailed how the first violation came immediately after the redeployment of the IDF along the so-called Yellow Line, ‘when Hamas first sent [civilian] children in order to provoke the IDF, in order to check if the IDF is aware enough and ready enough.’

‘And then they sent militants of Hamas, and some of them were even killed along the yellow line,’ he said.

‘They continue reconstituting themselves and attacking the IDF by using the tunnels, using the shafts going out, because they now feel much freer, because the IDF left the populated area,’ he explained.

Michael also cited Hamas’ ‘butchering’ of civilians ‘because they suspect that they collaborated with Israel, or because they are afraid that these hamulas or clans might oppose them in the future… and weaken them.’

In response to Sunday’s attack, the IDF launched air and ground strikes across southern Gaza.

‘The IDF also struck and dismantled six kilometers of underground terrorist infrastructure, using over 120 munitions. The underground site was used by the terrorist organization to advance attacks against the State of Israel,’ it said in a statement.

‘The IDF will continue to respond firmly and will operate to eliminate any threat to the State of Israel,’ it said.

Israel simultaneously announced a suspension of all humanitarian aid to the Gaza Strip. 

Michael warned that Hamas has no intention of dismantling itself and cooperating with the plan when it comes to demilitarizing the Gaza Strip and establishing a mechanism of alternative governance.

‘Hamas is still using the tunnels, and intends to reconstruct the tunnels that were destroyed by Israel, because they intend to continue the war against Israel,’ he said.

He said that the militant organization has been rebuilding its ranks and reasserting control in the Strip.

‘They immediately recruited [thousands] of people and deployed them and are butchering their own people,’ Michael said.

‘They do not intend to give up on their position and influence in the Gaza Strip. They do not accept the idea of dismantling themselves. And they do not accept the idea that a foreign force or board will govern the Gaza Strip,’ he concluded.

The incident comes just days after a U.S.-brokered ceasefire, which took effect Oct. 10, temporarily halted the two-year war between Israel and Hamas. 

Under the deal, hostages were released in exchange for Palestinian prisoners, and a ceasefire was declared.

Later on Sunday, the IDF announced the resumption of the ceasefire, following retaliatory strikes.

‘In accordance with the directive of the political echelon and following a series of significant strikes in response to Hamas’ violations, the IDF has begun the renewed enforcement of the ceasefire,’ a statement read.

‘The IDF will continue to uphold the ceasefire agreement and will respond firmly to any violation of it,’ the military added.

In a statement, Israeli UN Ambassador Danny Danon said: ‘Earlier today, two IDF soldiers, Maj. Yaniv Kula and Staff Sgt. Itay Yavetz, were killed by Hamas terrorists in Rafah in what was a flagrant violation of the ceasefire agreement.’

‘We mourn their loss and send our condolences to their families. Israel has abided by the terms of the ceasefire agreement, but we will make it clear to Hamas terrorists that the IDF will do whatever it takes to protect Israel’s security,’ Danon added.

Michael, meanwhile, predicted delays in reopening the Rafah Crossing, a critical entry point for aid and movement.

‘I don’t think Rafah Crossing will open tomorrow,’ he said. ‘It will take several days until it is opened,’ he said.

This post appeared first on FOX NEWS

President Donald Trump said he believes Venezuela is ‘feeling heat’ amid his administration’s war against alleged drug boats in the Caribbean, which has taken out at least two vessels in just the past week. 

Although Trump has said the strikes are intended to curb the influx of drugs into the United States, experts and some lawmakers contend that they serve another purpose: to exert pressure on Venezuelan President Nicolás Maduro so he’s ousted from power. 

‘The Trump administration is likely attempting to force Maduro to voluntarily leave office through a series of diplomatic moves, and now military action and the threat thereof,’ Brandan Buck, a foreign policy analyst at the Cato Institute, said in an email to Fox News Digital Thursday. ‘Whether this constitutes a ‘regime change’ or something else is a question of semantics.’ 

The Trump administration repeatedly has said it does not recognize Maduro as a legitimate head of state, but instead, a leader of a drug cartel. In August, the Trump administration upped the reward for information leading to Maduro’s arrest to $50 million, labeling him ‘one of the largest narco-traffickers in the world.’

So far, the Trump administration has been tight-lipped when asked about Maduro, and Trump declined to answer Wednesday when asked if the CIA had the authority to ‘take out’ Maduro. 

However, Trump confirmed that he authorized the CIA to conduct covert operations in Venezuela, after the New York Times reported Wednesday he signed off on the move. Trump told reporters he did so because Venezuela has released prisoners into the U.S., and that drugs were coming into the U.S. from Venezuela through sea routes. 

Additionally, Trump confirmed Friday that Maduro offered to grant the U.S. access to Venezuelan oil and other natural resources, claiming the Venezuelan leader didn’t want to ‘f*** around’ with the U.S. 

Still, these recent strikes are unlikely to majorly undermine drug flow into the U.S., according to Buck. 

‘It is more likely that those strikes are part of this incremental effort to dislodge Maduro than merely an effort to wage war on the cartels,’ Buck said. ‘Pacific and overland routes through Mexico are considerably more prolific, and Venezuela itself is a relatively minor player, especially when it comes to fentanyl.’ 

The Trump administration has employed maritime forces to address drug threats, and has bolstered naval assets in the Caribbean in recent months. For example, Trump has sent several U.S. Navy guided missile destroyers to enhance the administration’s counter-narcotics efforts in the region starting in August.

Geoff Ramsey, a senior fellow at the Atlantic Council international affairs think tank, said that the Trump administration wants these additional forces to encourage the Venezuelan military to take matters into their own hands. 

‘What President Trump is hoping is that this deployment will signal to the Venezuelan military that they should rise up against Maduro themselves,’ Ramsey said in a Thursday email to Fox News Digital. ‘The problem is that we haven’t seen this approach bear fruit in twenty years of trying. Maduro is terrible at governing, but good at keeping his upper ranks fat and happy while the people starve.’

‘What is needed here is some kind of a road map, or a blueprint for a transition, that can be more attractive to the ruling party and those around Maduro who might secretly want change but need to see a future for themselves in a democratic Venezuela,’ Ramsey said. 

Meanwhile, the second Trump administration has adopted a hard-line approach to address the flow of drugs into the U.S., and designated drug cartel groups like Tren de Aragua, Sinaloa and others as foreign terrorist organizations in February.

Additionally, the White House sent lawmakers a memo Sept. 30 informing them that the U.S. is now participating in a ‘non-international armed conflict’ with drug smugglers, and has conducted at least six strikes against vessels off the coast of Venezuela. The U.S. seized survivors from the most recent strike Thursday — the first one involving survivors. At least 28 other individuals have died from previous strikes. 

Lawmakers on both sides of the aisle have voiced concerns over the legality of the strikes, and Sens. Adam Schiff, D-Calif., and Tim Kaine, D-Va., filed a war powers resolution in September to bar U.S. forces from engaging in ‘hostilities’ against certain non-state organizations.

The resolution failed in the Senate by a 51–48 margin on Oct. 8, but Republicans Rand Paul of Kentucky and Lisa Murkowski of Alaska voted alongside their Democratic counterparts for the resolution.

On Friday, Schiff, Kaine and Paul introduced another narrower war powers resolution that would block U.S. armed forces from participating in ‘hostilities’ against Venezuela specifically. The lawmakers said the resolution came in response to Trump’s comments considering land operations in Venezuela. 

‘The Trump administration has made it clear they may launch military action inside Venezuela’s borders, and won’t stop at boat strikes in the Caribbean,’ Schiff said in a statement Friday. ‘In recent weeks we have seen increasingly concerning movements and reporting that undermine claims that this is merely about stopping drug smugglers. Congress has not authorized military force against Venezuela. And we must assert our authority to stop the United States from being dragged—intentionally or accidentally—into full-fledged war in South America.’

When asked about lawmakers’ concerns about the legality of the strikes, Trump dismissed them and said that lawmakers were informed the vessels carried drugs. 

‘But they are given information that they were loaded up with drugs,’ Trump said on Tuesday. ‘And that’s the thing that matters. When they’re loaded up with drugs, they’re fair game. And every one of those ships were and they’re not ships, they’re they’re boats.’ 

The Associated Press contributed to this report. 

This post appeared first on FOX NEWS

I went to England on a history vacation. It turned into an archaeological expedition, uncovering the bones of a once-great civilization. 

All the tourist sites are still there. You can still see the changing of the guard at Buckingham Palace, recall the ‘V’ for victory in the Churchill War Rooms or be inspired to pray at Westminster Abbey. But those are mere historical artifacts, like the pyramids of Egypt or the Acropolis in Greece. The ideals and most of the people who believe in them are long gone.

I was in London less than 24 hours before a terror attack killed two people in a Manchester synagogue. Police also killed the terrorist, a Syrian-born, 35-year-old immigrant named Jihad Al-Shamie, who they said had pledged himself to ISIS. Two innocent Jewish people are dead and a walking, talking metaphor was the cause. Jewish citizens admitted the assault was shocking but not surprising, given the rise of antisemitism in England. 

Two days later, thousands of ‘pro-Palestinians’ held a protest around Trafalgar Square. I watched police arrest a few radicals, while the crowd chanted, ‘Free Palestine.’ British Prime Minister Keir Starmer urged everyone not to protest on the Oct. 7th anniversary of the attack on Israel because he said it was ‘un-British.’ Unfortunately, it’s all too British these days. Britain has imported millions of people who hold no allegiance to its nation or its beliefs. They brought with them both a hatred of Jewish people and Western civilization. 

On Oct. 11, hundreds of thousands of ‘pro-Palestine’ protesters marched in London, shutting down streets and businesses. Even the ceasefire in Gaza didn’t satisfy them. It’s Starmer’s fault. He recognized a Palestinian state, rewarding Hamas for its barbaric assault on Israel and emboldening the protesters. 

Now, the government has to try to look good. It told universities they must ‘take stronger action to protect Jewish students,’ according to Reuters. But, a new YouGov poll says one out of five Britons holds antisemitic views. The message to Jews in England seems disturbingly similar to what it was in 1930s Germany: get out while you still can.

That is only one aspect of the failed British state. Some British people understand they had their history and culture stolen from them, but fear their government enough that they are unwilling or unable to do anything about it. One resident I met was afraid to even wear the British flag for fear of arrest. The same individual referred to England as a ‘tinder box’ that could turn into a civil war.

Those feelings aren’t surprising. A Labour Party member of the British Parliament, Jeevun Sandler, came out on Oct. 12, urging England to take down its flag from lamp posts because it was seen as ‘unwelcoming’ to immigrants. A local politician was investigated by police after she said she was ‘born and bred here.’ And a recent study from the University of Leicester’s Centre for Hate Studies complains that rural England is ‘overwhelmingly White’ and needs ‘inclusion.’ 

It’s not just politics. Canterbury Cathedral, a truly majestic monument to Christianity and Western civilization, was turned into a site for a graffiti-like art demonstration of England’s decline and fall. Christianity Today explains it as an, ‘art exhibit titled ‘Hear Us,’ which features temporary graffiti stickers that were slapped on Canterbury’s stone pillars and aim to highlight minorities while posing challenging questions to God.’ Artist Alex Vellis self describes as ‘an agender goblin-thing.’ Just the person you’d pick to decorate one of the world’s most famous religious sites.

What Vellis did is not art. It’s desecration. Thank God, I saw the cathedral just before this betrayal.

Major institutions embraced the guilt complex that causes all this. It is common for tour guides, museum employees and docents to fill their talks with leftist talking points about climate change and immigration. Many historic sites I visited were quick to demonize British history. Explorer and privateer Sir Francis Drake, who heroically defended England against the Spanish armada, is slammed as an enslaver at the very maritime museum he helped inspire.

British media is worse. The BBC is almost laughably left wing. It layered discussions of the Manchester terror attack with the typical refrain, ‘but Israel.’ Other outlets weren’t as bad, but that’s not saying much. Even commercials show the built-in biases. I saw at least 13 Unicef UK Ads on my television. Nine were about providing aid to Gaza, one more was for Yemen. There were no ads about helping Christians being genocided In Africa. Or even aiding Muslims in China or Myanmar, where they are also being persecuted. Of course, they aren’t fighting Israel in those locations.

Starmer’s many failures make him wildly unpopular and the Reform Party is polling high, looking like it could sweep future elections. The British response is to crack down even more. Rather than defend its own history and culture, the government wars against them. Already, 12,000 people are arrested each year for what they say online. 

British politician and journalist Daniel Hannan summarized these problems with the question, ‘Why are so many British leaders anti-British?’

Those problems are already here in America, they simply haven’t taken root as strongly yet. England is perhaps 10 or 20 years ahead of us. It can serve as a warning or a peek at our inevitable decline. Our campuses are filled with indoctrinated young people, ignorant of history and eager to carry whatever banner will tear down America and the West. It doesn’t matter if it’s the flag of communism or Hamas.

There are some in England who haven’t given up. But the fear is that it is too late. And looking around England, it’s hard to feel otherwise. For America, it’s not too late… yet.

This post appeared first on FOX NEWS

Senate Republicans are worried about the precedent that Senate Democrats have set for future funding fights as the shutdown continues into its 20th day.

Senate Minority Leader Chuck Schumer, D-N.Y., and the Democratic caucus have dug in deep on their demand for an extension to expiring Obamacare subsidies and have worked to spin the narrative from a battle to fund the government to a fistfight for healthcare.

But it’s been over three weeks since Schumer and Democrats blocked Republicans’ first attempt to pass the House GOP’s continuing resolution (CR). And since then, there are no signs that Democrats are willing to back down from their demands.

‘I think Schumer has basically sort of destroyed the institution of the Senate,’ Sen. Rick Scott, R-Fla., told Fox News Digital. ‘He has, you know, whether it’s what he’s done on the nominees or with this shutdown. I think he’s made government unmanageable. So, hopefully, this is not the way we continue to operate.’

Informal talks between the parties have ebbed and flowed over the course of the shutdown, but neither side is any closer to an off-ramp than they were when the first vote failed late last month.

Sen. Markwayne Mullin, R-Okla., has been involved in those talks but noted that this week they have been fading. When asked if he was worried that Democrats’ shutdown posture might be replicated in the future, he told Fox News Digital, ‘I can’t worry about their position.’

‘It doesn’t make sense,’ he said. ‘If there was a strategy behind it, OK, we get out, we can figure out how to move them. But there is no strategy. It’s just like, burn it all down.’

Senate Republicans now view Democrats’ shutdown position as a hostage-taking exercise, with no real ground for negotiations until after the government reopens.

‘We can’t negotiate with them until we come out of shutdown,’ Sen. John Hoeven, R-N.D., told Fox News Digital. ‘You can’t hold the government hostage. And that’s why it’s very important — we’ve said we’ll work on all these different issues they want to bring up. But you can’t shut down the government, hold the government hostage as part of negotiation.’

The informal talks, which Republicans quickly note aren’t full-blown negotiations, have produced an olive branch of sorts from Senate Majority Leader John Thune, R-S.D., who signaled to Senate Democrats that he would offer them a vote on the Affordable Care Act (ACA) premium tax credits if they voted to reopen the government.

But for a 10th time on Thursday, they blocked his effort to turn the lights back on and then hours later blocked a procedural move to allow lawmakers to consider the annual defense spending bill.

In both instances, Democrats wanted guarantees that Thune and Republicans could not provide.

‘The Dems, someday, they’re going to rue the day they did this, because we have offered up an open appropriations process, regular order, doing things that way,’ Thune told Fox News Digital.

‘I think it’s unfortunate, but it’s a reality that we’re dealing with,’ he continued. ‘And I hope they change their mind and realize that it’s in everybody’s best interest to try and at least get the government open and then start going to work and funding the government the old-fashioned way.’

Many Republicans hope that after the ‘No Kings’ rally in Washington, D.C., over the weekend that Senate Democrats may have a change of heart.

But others see it as a performative opportunity for congressional Democrats to show they are fighting back against President Donald Trump and the GOP.

‘Typically, if you reward bad behavior, you get more bad behavior,’ Sen. Bernie Moreno, R-Ohio, told Fox News Digital. ‘That’s what the Democrats are basically doing. They’re pretending that President Trump didn’t get elected last November. That’s basically the whole fight, because they have the goofballs that are going to be here Saturday, so they have to show the goofballs they’re fighting.’

This post appeared first on FOX NEWS